黑料网

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 1089

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
  • ICMJE
Share This Page

Biomarker Discovery

Biomarker discovery involves identifying biological markers—molecules found in blood, other body fluids, or tissues—that indicate the presence or progression of a disease, or the effects of a treatment. These biomarkers can help in diagnosing diseases, predicting outcomes, and monitoring therapeutic responses.
Biomarker discovery is crucial for advancing precision medicine by providing insights into disease mechanisms and treatment effects. It involves techniques such as genomics, proteomics, and metabolomics to find novel biomarkers that can be used for early diagnosis, personalized treatment plans, and monitoring disease progression.

Biomarker Discovery